Featured Interview
Minshan Chen: combination of TACE and RFA can improve the treatment of HCC
Abstract
Transcatheter arterial chemoembolization (TACE) is the most widely used therapy for mid-stage hepatocellular carcinoma (HCC), while radiofrequency ablation (RFA) is commonly used as a therapy for early-stage HCC. This study combines RFA with TACE for the treatment of HCC. So where did this idea come from? Is there any plan for a follow-up research?
